R03 CA230950/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2019	1
2021	1
2022	1
2025	0

Page 1

Targeting treatment options for castration-resistant prostate cancer.

Miller DR, Ingersoll MA, Teply BA, Lin MF. Miller DR, et al. Am J Clin Exp Urol. 2021 Feb 15;9(1):101-120. eCollection 2021. Am J Clin Exp Urol. 2021. PMID: 33816699 Free PMC article. Review.

Dynamics of antioxidant heme oxygenase-1 and pro-oxidant p66Shc in promoting advanced prostate cancer progression.

Miller DR, Ingersoll MA, Chou YW, Kosmacek EA, Oberley-Deegan RE, Lin MF. Miller DR, et al. Free Radic Biol Med. 2022 Nov 20;193(Pt 1):274-291. doi: 10.1016/j.freeradbiomed.2022.10.269. Epub 2022 Oct 17. Free Radic Biol Med. 2022. PMID: 36265795 Free PMC article.

p66Shc protein through a redox mechanism enhances the progression of prostate cancer cells towards castration-resistance.

Miller DR, Ingersoll MA, Chatterjee A, Baker B, Shrishrimal S, Kosmacek EA, Zhu Y, Cheng PW, Oberley-Deegan RE, Lin MF. Miller DR, et al. Free Radic Biol Med. 2019 Aug 1;139:24-34. doi: 10.1016/j.freeradbiomed.2019.05.015. Epub 2019 May 14. Free Radic Biol Med. 2019. PMID: 31100478 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year